Sleep Apnea Diagnostics Market Dynamics and Trends by 2028

The sleep apnea diagnostics market is projected to reach US$ 685.66 million by 2028 from US$ 473.95 million in 2021; it is estimated to grow at a CAGR of 5.4% from 2021 to 2028

Sleep apnea is a common type of sleep disorder that happens when an individual is having trouble in breathing during sleep where breathing repeatedly stops and starts. Sleep apnea devices are primarily provided as diagnostic and therapeutic devices in order to treat obstructive sleep apnea syndrome, central sleep apnea syndrome and complex sleep apnea syndrome. Continuous positive airway pressure is widely recommended device to treat obstructive sleep apnea. 

Factors such as increased sleep apnea prevalence, technological developments, and rising geriatric population are boosting the sleep apnea diagnostics market growth. However, the high cost of diagnosis, and challenges in medical device industry hamper the growth of the market.  

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Sleep Apnea Diagnostics Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Market Insights

Increased Prevalence of Sleep Apnea Boosts Sleep Apnea Diagnostics Market Growth

Obstructive sleep apnea (OSA) is a common disorder, characterized by the repetitive, complete or partial closure of the upper airway during sleep. This airway is helpful in the fragmentation of sleep and oxygen desaturation. The disorder causes significant morbidity, especially in the form of impairment of daytime functioning and degraded quality of life. As per recent controlled trials, oral appliances are up to 50.0% efficient in controlling the OSA among patients, including severe cases.

According to a survey conducted by Needham & Company, an investment firm, over one-third of OSA tests were conducted in patients' homes in 2018, up from 15% in 2013. As a result, companies are concentrating their efforts on the development of home-care sleep apnea equipment. In June 2019, the FDA approved Itamar Medical, an Israel-based business, for a disposable home sleep apnea test. ResApp (Australia), a firm that develops smartphone applications for the diagnosis and management of respiratory disorders, has launched SleepCheck, an at-home screening app for the OSA.

Due to the rising use of the polysomnography (PSG) device in the various regions, the need for improved and technologically advanced PSG devices for the diagnosis of OSA has surged substantially, thus driving the global sleep apnea diagnostics market.

Product and Service-Based Insights

Based on product, the sleep apnea diagnostics market is segmented into polysomnography (PSG) device, home sleep testing devices, oximeter, actigraphy monitoring device, and sleep apnea screening device. The oximeter segment is further segmented into fingertip oximeter, handheld oximeter, wrist-worn oximeter, and tabletop oximeter. The PSG device segment is expected to hold the largest share of the market in 2021, and it is further expected to register the highest CAGR during the forecast period.

End-User -Based Insights

Based on end-user, the sleep apnea diagnostics market is segmented into hospitals and sleep laboratories, and home care settings. The hospitals and sleep laboratories segment is expected to hold a larger market share in 2021, whereas the home care settings segment is expected to register a higher CAGR in the market during the forecast period

Various companies operating in the sleep apnea diagnostics market are adopting strategies such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain brand name, and meet the growing demand from end users.

Sleep Apnea Diagnostics Market Regional Insights

The regional trends and factors influencing the Sleep Apnea Diagnostics Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Sleep Apnea Diagnostics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Sleep Apnea Diagnostics Market Report Scope

Sleep Apnea Diagnostics Market Players Density: Understanding Its Impact on Business Dynamics

The Sleep Apnea Diagnostics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Sleep Apnea Market – by Product

• Polysomnography (PSG) Device
• Home Sleep Testing Devices
• Oximeter
  • Fingertip Oximeter
  • Hand held oximeter
  • Wrist-Worn Oximeter
  • Tabletop Oximeter
• Actigraphy Monitoring Device
• Sleep Apnea Screening Device

Sleep Apnea Diagnostics Market – by End User

• Hospital and sleep laboratories
• Home Care Settings 

Sleep Apnea Diagnostics Market – by Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of Asia Pacific
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa
• South America (SAM)
  • Brazil
  • Argentina
  • Rest of South and Central America

Company Profiles

•  Drive DeVilbiss International
• ResMed Inc.
• Nihon Kohden Corporation
• SOMNOmedics GmbH
• Cleveland Medical Devices Inc
• Koninklijke Philips N.V.
• Cadwell Industries Inc
• Natus Medical Incorporated
• Itamar Medical Ltd.
• Compumedics Limited